BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1878697)

  • 41. The significance of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
    Goldman JM
    Biol Blood Marrow Transplant; 2013 May; 19(5):679-80. PubMed ID: 23467125
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chronic myeloid leukosis. Current status].
    Cervantes F
    An Med Interna; 1991 Jun; 8 Suppl 2():14-7. PubMed ID: 1878465
    [No Abstract]   [Full Text] [Related]  

  • 43. Marrow fibrosis associated with a Philadelphia chromosome.
    Nowell PC; Kant JA; Finan JB; Cassileth PA; Hanson CA
    Cancer Genet Cytogenet; 1992 Mar; 59(1):89-92. PubMed ID: 1372840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bone marrow autograft treated with mafosfamide in the acceleration phase in chronic myeloid leukemia. Inversion of the clinical development].
    Fouillard L; Van Den Akker J; Laporte JP; Najman A; Perot C; Lopez M; Douay L; Isnard F; Taillemite JL; Gorin NC
    Presse Med; 1989 Nov; 18(36):1785-8. PubMed ID: 2530566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experiences with the determination of chimaera bcr-abl messages in bone marrow and peripheral blood samples in chronic myeloid leukaemia.
    Páldi-Harris P; Földi J
    Br J Haematol; 1995 Mar; 89(3):684-5. PubMed ID: 7734383
    [No Abstract]   [Full Text] [Related]  

  • 46. A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia.
    Jin C; Zhu X; Xiao M; Liu S; Liu X; Liu J; Xu X; Yi S; Meng L
    Ann Lab Med; 2018 Mar; 38(2):169-171. PubMed ID: 29214763
    [No Abstract]   [Full Text] [Related]  

  • 47. Chronic myeloid leukemia following heart transplantation and immunosuppression with tacrolimus.
    Sbenghe MM; Florea AD; Mather P; Gitelson E
    Clin Adv Hematol Oncol; 2011 Aug; 9(8):623-7. PubMed ID: 22236991
    [No Abstract]   [Full Text] [Related]  

  • 48. Identification of a BCR polymorphism in a bone marrow donor: diagnostic implications.
    Rosenblum-Vos LS; Griffin CA
    Leukemia; 1998 Sep; 12(9):1499-501. PubMed ID: 9737706
    [No Abstract]   [Full Text] [Related]  

  • 49. Testicular relapse in Philadelphia chromosome positive acute lymphoblastic leukaemia.
    O'Brien DV; Craig JM; Secker-Walker LM; Boughton BJ
    Acta Haematol; 1993; 89(2):100-3. PubMed ID: 8503240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation of induced pluripotent stem cell line KUMi002-A with normal karyotype from a patient with Philadelphia chromosome-positive chronic myeloid leukemia.
    Kim JH; Kang KW; Lee BH; Park Y; Kim BS
    Stem Cell Res; 2021 Aug; 55():102465. PubMed ID: 34303284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic myeloid leukaemia: a therapeutic challenge.
    Mughal TI; Goldman JM
    Ann Oncol; 1995 Sep; 6(7):637-44. PubMed ID: 8664183
    [No Abstract]   [Full Text] [Related]  

  • 52. Recurrence of Philadelphia chromosome-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia: confirmation by microsatellite studies.
    McCann SR; Lawler M; Humphries P; Bacigalupo A; Podesta M; Frassoni F; Van Lint MT; Marmont A
    Blood; 1992 May; 79(10):2803-5. PubMed ID: 1586731
    [No Abstract]   [Full Text] [Related]  

  • 53. Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Shah NK; Wagner J; Santos G; Griffin CA
    Cancer Genet Cytogenet; 1992 Jul; 61(2):183-92. PubMed ID: 1638501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of clinical relapse after bone-marrow transplantation by PCR for Philadelphia-positive acute lymphoblastic leukaemia.
    Miyamura K; Morishima Y; Tanimoto M; Saito H; Kojima S; Kodera Y; Mizutani S
    Lancet; 1990 Oct; 336(8719):890. PubMed ID: 1976927
    [No Abstract]   [Full Text] [Related]  

  • 55. Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia.
    Chase A; Parker S; Kaeda J; Sivalingam R; Cross NC; Goldman JM
    Blood; 2000 Jul; 96(2):777-8. PubMed ID: 10950516
    [No Abstract]   [Full Text] [Related]  

  • 56. The treatment of chronic myeloid leukaemia--much still to be achieved.
    Goldman JM
    J Intern Med; 1994 Apr; 235(4):289-91. PubMed ID: 8151260
    [No Abstract]   [Full Text] [Related]  

  • 57. A case report of a 33-year chronic phase survivor of chronic myeloid leukemia.
    Ji O; Shen Q; Zhang YC; Ji JM; Zhu GR; Lin L; Kong XT; Xia W; Jiang PJ
    Med Oncol; 2012 Jun; 29(2):1102-4. PubMed ID: 21359860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The karyotype in a case of chronic myeloid leukemia: the Philadelphia chromosome].
    BAGUENA CANDELA R; FORTEZA BOVER G
    Med Esp; 1962 Jul; 48():36-9. PubMed ID: 13968970
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic myeloid leukaemia, BCR-ABL1-positive, in accelerated phase with marked eosinophilia with eosinophil atypia.
    Richardson AI; Skikne BS; Woodroof J
    Br J Haematol; 2020 Mar; 188(5):599. PubMed ID: 32032978
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytogenetic events after bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia.
    Zaccaria A; Rosti G; Testoni N; Santucci MA; Tassinari A; Celso B; Buzzi M; Miggiano MC; Tura S
    Leuk Res; 1991; 15(5):289-96. PubMed ID: 2046382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.